60 Degrees Pharmaceuticals Inc (SXTP) concluded trading on Wednesday at a closing price of $2.86, with 4.03 million shares of worth about $11.52 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.04% during that period and on June 04, 2025 the price saw a loss of about -1.72%. Currently the company’s common shares owned by public are about 1.47M shares, out of which, 1.38M shares are available for trading.
Stock saw a price change of 24.35% in past 5 days and over the past one month there was a price change of 20.68%. Year-to-date (YTD), SXTP shares are showing a performance of -55.66% which decreased to -83.68% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.41 but also hit the highest price of $35.99 during that period. The average intraday trading volume for 60 Degrees Pharmaceuticals Inc shares is 1.52 million. The stock is currently trading 18.15% above its 20-day simple moving average (SMA20), while that difference is up 15.66% for SMA50 and it goes to -34.84% lower than SMA200.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) currently have 1.47M outstanding shares and institutions hold larger chunk of about 2.04% of that.
The stock has a current market capitalization of $4.22M and its 3Y-monthly beta is at 2.87. It has posted earnings per share of -$31.18 in the same period. It has Quick Ratio of 2.71 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SXTP, volatility over the week remained 5.42% while standing at 7.55% over the month.
Analysts are in expectations that 60 Degrees Pharmaceuticals Inc (SXTP) stock would likely to be making an EPS of -1.24 in the current quarter, while forecast for next quarter EPS is -1.21 and it is -5.36 for next year. For the current quarter EPS, analysts have given the company a lowest target -1.24 which is -1.24 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -20.55 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 82.67% while it is estimated to increase by 14.23% in next year. EPS is likely to grow at an annualized rate of 71.59% for next 5-years, compared to annual growth of 12.29% made by the stock over the past 5-years.
